TABLE 2.
Different conformations in MyoD versus A114N mutant proteins inferred from Gal fusion experimentsa
| Gal4 fusion constructb | G5-LacZ activityc |
|---|---|
| Control | 1 |
| (1–318)MyoD | 20 |
| (1–318)A114N | 200 |
| (1–75)MyoD | 2,000 |
| (1–101)MyoD | 600 |
| (1–127)MyoD | 1 |
| (1–127)A114N | 1 |
| (1–161)MyoD | 0.3 |
| (1–161)A114N | 0.3 |
NIH 3T3 cells were transfected with 1.5 μg of G5-E1b-LacZ reporter plasmid and 1.5 μg of Gal4 fusion constructs on 60-mm-diameter duplicate plates.
Control, activity of the reporter plus empty fusion vector; (1–75)MyoD is a Gal4 fusion construct carrying the 75 amino-terminal residues of MyoD including the previously defined N-terminal activation domain (aa 1 to 53); (1–101), (1–127), and (1–161) indicate proteins that are truncated at the end of the Cys- and His-rich domain, the junction of the basic region and helix 1, and the end of helix 2, respectively; (1–318) indicates full-length proteins.
The results were derived from 5 to 10 independent experiments and are expressed as the ratio to the activity of the control.